- Home
- MLSS vs CVKD Comparison
MLSS vs CVKD Comparison
Compare MLSS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLSS | CVKD |
|---|---|---|
| Founded | 1989 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 20.7M |
| IPO Year | 1995 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MLSS | CVKD |
|---|---|---|
| Price | $0.29 | $8.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 516.4K | 61.9K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,929,517.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $7.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.59 | N/A |
| 52 Week Low | $0.23 | $6.42 |
| 52 Week High | $1.39 | $22.90 |
Technical Indicators
Market Signals| Indicator | MLSS | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 46.03 |
| Support Level | $0.28 | $6.55 |
| Resistance Level | $0.30 | $8.79 |
| Average True Range (ATR) | 0.03 | 0.57 |
| MACD | 0.00 | 0.23 |
| Stochastic Oscillator | 73.77 | 65.83 |
Price Performance
Historical ComparisonAbout MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.